Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. (FFPC), established in 1979, was 100% acquired by Livzon Pharmaceutical Group Inc. in 2004, with the purpose of developing it into a first–class fermented API production center and research & development (R&D) center.

FFPC has 2 manufacturing sites in Fujian province, which have modern equipment, and advanced fermentation and extraction technologies. The facilities been approved by USFDA and EUGMP and received SGMP and CGMP certifications. The main products produced by FFPC are vancomycin HCl, teicoplanin, milbemycin oxime, and kanamycin acid sulphate. Vancomycin HCl and teicoplanin have obtained CEP certificates, and kanamycin mono sulfate and kanamycin acid sulfate have passed World Health Organization (WHO) inspection.